![Robbert Hoogeboom](/newimages/folsm/person-profile/scps/robbert-hoogeboom.x30d9f36e.png?f=webp)
Dr Robbert Hoogeboom
Lecturer in Lymphoma
Research interests
- Cancer
Biography
Dr Robbert Hoogeboom is a Lecturer in Lymphoma within the Comprehensive Cancer Centre. He obtained a PhD at the Academic Medical Centre in Amsterdam, The Netherlands and subsequently became a postdoc at the National Institute for Medical Research/The Francis Crick Institute. In 2018, he joined King's College London as a lecturer. He leads a research group that focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma. His team uses high content imaging of primary patient cells and novel in vivo mouse models to study the context in which malignant B cells see antigen and how antigen stimulation and BCR signalling influence the behaviour of the tumour cells and disease progression.
Research
![Lymphoma Signalling 780x450](/newimages/folsm/hero-banner/scps/lymphoma-signalling-780x450.xac76d5d5.png?crop=780,440,0,5&width=380&height=215&fit=crop&f=webp)
Lymphoma Signalling
Our work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma.
Research
![Lymphoma Signalling 780x450](/newimages/folsm/hero-banner/scps/lymphoma-signalling-780x450.xac76d5d5.png?crop=780,440,0,5&width=380&height=215&fit=crop&f=webp)
Lymphoma Signalling
Our work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma.